Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 7/20 | 0.58 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.43 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31345777 | 1.00 | ERN1 (0.58) | ERN1GABBR2GABBR1ALDH1A1MEN1 | |
| SCHEMBL10323583 | 0.81 | ERN1 (0.58) | ERN1 | |
| SCHEMBL29592823 | 0.81 | ERN1 (0.58) | ERN1 | |
| SCHEMBL30222051 | 0.81 | ERN1 (0.47) | ERN1GABBR2GABBR1ALDH1A1MEN1 | |
| SCHEMBL207854 | 0.81 | ERN1 (0.47) | ERN1GABBR2GABBR1ALDH1A1MEN1 | |
| SCHEMBL544809 | 0.80 | ERN1 (0.78) | ERN1CYP3A4TSHR | |
| SCHEMBL49614 | 0.80 | CA2 (0.64) | GABBR2GABBR1ALDH1A1MEN1KMT2A | |
| SCHEMBL30646074 | 0.79 | ERN1 (0.67) | ERN1GABBR2GABBR1ALDH1A1MEN1 | |
| SCHEMBL29467330 | 0.79 | ALOX5 (0.49) | ERN1GABBR2GABBR1ALDH1A1MEN1 | |
| SCHEMBL187267 | 0.79 | ALOX5 (0.49) | ERN1GABBR2GABBR1ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036813-A | Schiff base cobalt complex, preparation method and application | 安徽大学 | 2026-05-15 | — | — | CN | claimed |
| CN-115894347-B | Tetranuclear cobalt complex based on Salen ligand, preparation method and application thereof | 广西师范大学 | 2025-03-21 | — | — | CN | claimed |
| CN-115894347-A | Salen ligand-based tetranuclear cobalt complex, and preparation method and application thereof | 广西师范大学 | 2023-04-04 | — | — | CN | claimed |
| CN-101270112-A | Preparation of polymerization type chiral catalyst, preparation and application of cyclic carbonates with optical activity | UNIV LANZHOU (CN) | 2008-09-24 | — | — | CN | claimed |
| CN-122036813-A | Schiff base cobalt complex, preparation method and application | 安徽大学 | 2026-05-15 | — | — | CN | disclosed |
| CN-122036813-A | Schiff base cobalt complex, preparation method and application | 安徽大学 | 2026-05-15 | — | — | CN | disclosed |
| CN-115894347-B | Tetranuclear cobalt complex based on Salen ligand, preparation method and application thereof | 广西师范大学 | 2025-03-21 | — | — | CN | disclosed |
| CN-117777327-A | Manganese-based catalyst, preparation method and application | 铜仁学院 | 2024-03-29 | — | — | CN | disclosed |
| CN-115894347-A | Salen ligand-based tetranuclear cobalt complex, and preparation method and application thereof | 广西师范大学 | 2023-04-04 | — | — | CN | disclosed |
| CN-115894950-A | Pyrazole functionalized metal-salen-based chiral MOFs and preparation method thereof | 嘉兴学院 | 2023-04-04 | — | — | CN | disclosed |
| EP-2618662-B1 | SYNTHESIS OF SUBSTITUTED SALICYLALDEHYDE DERIVATIVES | SAUDI ARAMCO TECH CO (SA) | 2019-11-06 | — | — | EP | disclosed |
| US-10040800-B2 | Synthesis of substituted salicylaldehyde derivatives | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2018-08-07 | — | — | US | disclosed |
| US-20050004204-A1 | 2-Iminopyrrolidine derivatives | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2005-01-06 | — | — | US | disclosed |
| CN-1503784-A | 2-iminopyrrolidine derivatives | ������������ʽ���� | 2004-06-09 | — | — | CN | disclosed |
| EP-1391451-A1 | 2-IMINOPYRROLIDINE DERIVATES | Eisai Co., Ltd. (JP) | 2004-02-25 | — | — | EP | disclosed |
| EP-1343740-A1 | PROCESS FOR OLIGOMERISING OR POLYMERISING ETHYLENE | Univation Technologies LLC (US) | 2003-09-17 | — | — | EP | disclosed |
| US-20030105250-A1 | Olefin oligomerization catalysts, their production and use | WHITEKER GREGORY T (US) | 2003-06-05 | — | — | US | disclosed |
| US-6531555-B2 | Using phenoxide/transition metal complexes and activator compound for polymerization of ethylene | UNIVATION TECHNOLOGIES, LLP | 2003-03-11 | — | — | US | disclosed |
| WO-2002049995-A1 | PROCESS FOR OLIGOMERISING OR POLYMERISING ETHYLENE | UNIVATION TECHNOLOGIES, LLC (US) | 2002-06-27 | — | — | WO | disclosed |
| US-20020077431-A1 | Olefin oligomerization catalysts, their production and use | UNIVATION TECHNOLOGIES, LLC | 2002-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050004204-A1 | 2-Iminopyrrolidine derivatives | H1-2, H1-3, H1-0 | ERN1 3042/4885GABBR2 1753/4885GABBR1 1658/4885 |
| US-10040800-B2 | Synthesis of substituted salicylaldehyde derivatives | ADSL, ALDH3A1, SUCLA2 | ERN1 3530/4885GABBR2 2277/4885GABBR1 2389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.